Meropenem Injection
Product Images NDC 51810-503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 51810-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Antibiotics Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Meropenem 01)

FDA Label Image

Image Description (Meropenem 1g Carton)

FDA Label Image

Principal Display Panel (1 g Vial Label)

Principal Display Panel (1 g Vial Label)
This text provides information about a medication called Meropenem. It includes details about the contents of each vial, instructions for intravenous preparation, dosage and administration guidelines, and manufacturer information. The medication is manufactured by Qilu Antibiotics Pharmaceutical Co., Ltd in China. The text also mentions the sodium content in the medication and the need to dilute it with an approved diluent before use. Additionally, it provides storage instructions and details about the expiration date.*
FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Principal Display Panel (500 mg Vial Carton)
The text appears to be a description of Meropenem for injection, USP. This medication is in the form of 500 mg per vial and is intended for intravenous use only. The package contains 10 x 500 mg single-dose vials.*
FDA Label Image

Principal Display Panel (500 mg Vial Label)

Principal Display Panel (500 mg Vial Label)
This text is a description of Meropenem for Injection, USP. It provides information on the contents, dosage, administration, preparation, storage, manufacturer, and product details such as NDC, dosage strength, and expiration date. The medication is to be used intravenously and each vial contains 500 mg of meropenem activity. The text also mentions the sodium content, storage conditions, and dilution instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.